Tagamet vs omeprazole
Pro Research Analysisby 
Searched over 200M research papers
Comparative Analysis of Tagamet vs Omeprazole
Cost-Effectiveness in Duodenal Ulcer Treatment
Tagamet and Omeprazole Cost Comparison
A study comparing the cost-effectiveness of Tagamet (cimetidine) and omeprazole in treating duodenal ulcers found that Tagamet, when combined with a two-week regimen of amoxicillin and metronidazole, was significantly more cost-effective than omeprazole combined with a two-week regimen of amoxicillin1. The costs for ulcer healing, Helicobacter pylori (Hp) eradication, and reducing ulcer recurrence were all lower in the Tagamet group compared to the omeprazole group1. This suggests that Tagamet may be a more economical choice for patients, especially those with ulcers less than 1 cm in diameter.
Efficacy in Ulcer Healing and Hp Eradication
Healing Rates and Hp Growth Inhibition
In a comparative study on rats, both Tagamet and omeprazole were effective in reducing the ulcer index, indicating their efficacy in ulcer healing2. However, while omeprazole showed significant inhibition of Hp growth, Tagamet did not exhibit any anti-Hp effects2. This suggests that while both drugs are effective in healing ulcers, omeprazole may be more beneficial in cases where Hp eradication is also a treatment goal.
Combined Treatment for Stress Ulcer Hemorrhage
Omeprazole and Thrombase Synergy
In the context of acute cerebral vascular disease (ACVD) and stress ulcer hemorrhage (SUH), a combination treatment of omeprazole and thrombase was found to be significantly more effective than Tagamet alone3. The total effective rate was 94.3% in the omeprazole and thrombase group compared to 34.3% in the Tagamet group, with no significant difference in side effects3. This indicates a potential synergistic effect of omeprazole when used in combination with thrombase for treating ACVD and SUH.
Conclusion
In summary, while Tagamet is more cost-effective for treating duodenal ulcers, omeprazole offers superior Hp eradication and shows enhanced efficacy when combined with thrombase for treating stress ulcer hemorrhage. The choice between Tagamet and omeprazole should be guided by the specific clinical context, cost considerations, and the need for Hp eradication.
Sources and full results
Most relevant research papers on this topic
Cost-effectiveness study on treatment of duodenal ulcer.
AMT therapy is more cost-efficient than OA therapy for treating duodenal ulcers, with acceptable ulcer healing rates, ability to cure Helicobacter pylori infection, and especially for patients with an ulcer 1 cm in diameter.
RCTEFFECT OF LANSOPRAZOLE ON GASTROC ULCER HEALING AND HELICOSACTER PYLORI GROWING
Lansoprazole effectively heals chronic gastric ulcers and inhibits Helicobacter pylori growth in vitro, with better results than omeprazole and tagamet.
Curative Observation on Acute Cerebral Vascular Disease and Stress Ulcer Hemorrhage with Combination Treatment with Omeprazole and Thrombase
Omeprazole and thrombase combined show a significant curative effect in treating acute cerebral vascular disease and stress ulcerative hemorrhage, with no significant difference in side effects.
RCTEsomeprazole tablet vs omeprazole capsule in treating erosive esophagitis.
Esomeprazole 40 mg is an effective and safe drug for treating Chinese erosive esophagitis patients, with common side effects being constipation and skin dryness.
RCTEffect of repeated injection and continuous infusion of omeprazole and ranitidine on intragastric pH over 72 hoursFigure 1
Omeprazole infusion provides superior high intragastric pH levels over the first 72 hours, while ranitidine shows rapid loss of antisecretory activity on days 2 and 3.
RCT
Highly CitedPharmacokinetic drug interaction profile of omeprazole with adverse consequences and clinical risk management
Omeprazole can cause adverse drug interactions with various medications, requiring enhanced clinical risk management to avoid adverse consequences.
Systematic Review
Rigorous JournalHighly CitedOmeprazole before endoscopy in patients with gastrointestinal bleeding.
Infusion of high-dose omeprazole before endoscopy accelerated the resolution of bleeding in ulcers and reduced the need for endoscopic therapy in patients with gastrointestinal bleeding.
RCT
Large Human TrialHighly CitedOmeprazole, a long-lasting inhibitor of gastric secretion.
Omeprazole effectively reduces gastric acid secretion in dogs, with 44% suppression still present after 24 hours.
RCT
Animal StudyOmeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.
Omeprazole is a promising drug for rapidly healing peptic ulcers and reducing gastric acid hypersecretion in patients with Zollinger-Ellison syndrome, with potential for major advances in these diseases.
Literature ReviewHighly CitedOmeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders.
Omeprazole is a well-tolerated and well-tolerated acid pump inhibitor for treating various acid-related disorders, with rapid healing and minimal relapse rates.
Literature ReviewHighly Cited